Patents by Inventor Mohan Ranjit Kumar Kocherla

Mohan Ranjit Kumar Kocherla has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20170137886
    Abstract: Disclosed herein are compositions and methods relevant to a novel Drug Metabolism Reserve Physiotype to determine the metabolic capacity of a human individual. The Drug Metabolism Reserve Physiotype allows the determination of the innate metabolic capacity of the patient relevant to antidepressant and stimulant treatment and can be predicted and diagnosed simply from a blood sample. In the disclosed method, an individual is genotyped for a plurality of polymorphisms in a gene encoding CYP2C9, a gene encoding CYP2C19 and a gene encoding CYP2D6, and the genotypes are used to produce four novel indices, which relate to the metabolic capacity of the human individual.
    Type: Application
    Filed: January 26, 2017
    Publication date: May 18, 2017
    Inventors: GUALBERTO RUANO, DAVID VICTOR VILLAGRA, MOHAN RANJIT KUMAR KOCHERLA, ANDREAS WINDEMUTH, JOHN W. GOETHE
  • Patent number: 9558320
    Abstract: Disclosed herein are compositions and methods relevant to a novel Drug Metabolism Reserve Physiotype to determine the metabolic capacity of a human individual. The Drug Metabolism Reserve Physiotype allows the determination of the innate metabolic capacity of the patient relevant to antidepressant and stimulant treatment and can be predicted and diagnosed simply from a blood sample. In the disclosed method, an individual is genotyped for a plurality of polymorphisms in a gene encoding CYP2C9, a gene encoding CYP2C19 and a gene encoding CYP2D6, and the genotypes are used to produce four novel indices, which relate to the metabolic capacity of the human individual.
    Type: Grant
    Filed: October 22, 2010
    Date of Patent: January 31, 2017
    Assignee: GENOMAS, INC.
    Inventors: Gualberto Ruano, David Victor Villagra, Mohan Ranjit Kumar Kocherla, Andreas Windemuth, John W. Goethe
  • Publication number: 20110098186
    Abstract: Disclosed herein are compositions and methods relevant to a novel Drug Metabolism Reserve Physiotype to determine the metabolic capacity of a human individual. The Drug Metabolism Reserve Physiotype allows the determination of the innate metabolic capacity of the patient relevant to antidepressant and stimulant treatment and can be predicted and diagnosed simply from a blood sample. In the disclosed method, an individual is genotyped for a plurality of polymorphisms in a gene encoding CYP2C9, a gene encoding CYP2C19 and a gene encoding CYP2D6, and the genotypes are used to produce four novel indices, which relate to the metabolic capacity of the human individual.
    Type: Application
    Filed: October 22, 2010
    Publication date: April 28, 2011
    Applicant: GENOMAS, INC.
    Inventors: Gualberto Ruano, David Victor Villagra, Mohan Ranjit Kumar Kocherla, Andreas Windemuth, John W. Goethe